Cochlear implant (CI) surgeons are faced with the increasingly difficult task of choosing the “right” device despite a growing number of choices and conflicting evidence regarding the relative importance of various anatomic, surgical, and device-specific factors.
ETI has been shown to have positive effects on multiple organ systems in cystic fibrosis patients.
Most current literature suggests that cefazolin is safe for surgical prophylaxis in patients with penicillin allergy.
The weight loss drug craze of the last couple of years brings important considerations for otolaryngologists, including how to manage gastric emptying before procedures for patients taking the medications and the possibility of the drugs being a new option for obstructive sleep apnea patients.
Electrocochleography (ECoG) has historically been used for measuring hearing thresholds and identifying endolymphatic hydrops in Ménière’s disease. More recently, ECoG application has expanded to monitor electrical potentials during cochlear implantation as an indirect measure of cochlear trauma.
Laryngeal reinnervation should be offered to all patients independent of patient age or duration of denervation, as it can improve voice and swallowing. Long-term denervation, however, may result in a smaller degree of improvement.
Staging severity of laryngopharyngeal reflux with more objective testing is crucial to understanding its natural history, forecasting response to treatment, and it may serve as a gateway to considering surgical treatments.
The use of tranexamic acid to reduce intraoperative bleeding may have applications in septorhinoplasty.
Randomized controlled trials with standardized hyperbaric oxygen therapy treatment protocols and attention to social determinants of health and other confounders are desperately needed to establish efficacy.
Adjuvant therapy may have a limited role in select patients with advanced JNAs to achieve acceptable outcomes while minimizing serious morbidity and mortality.